Furthermore, Jak2‐mediated phosphorylation of ARHGEF1 at Tyr738 activates RhoA, increasing VSMC contractility and vascular resistance—a key mechanism in hypertension [213]. The gene discussed is ARHGEF1; the disease is hypertensive disorder.